Search Results for "Mylan Atovaquone And Proguanil 250mg 100mg Tablet"

12:56 EST 20th December 2014 | BioPortfolio

Matching Channels

Pancreatic Cancer

The pancreas secretes a number of important hormones into the digestive tract and the blood stream. Cancers are most commonly exocrine than endocrine (neuroendocrine) tumors. Functional tumors secre...

Selective monoamine oxidase type B MAOB inhibitors

The clinical benefit of monoamine oxidase type B (MAO-B) inhibitors is thought to arise from an ability of these medications to enhance the level of dopamine by decreasing the catabolism. Additional...

Matching News

Otsuka Pharmaceutical to Launch L-Cartin FF Tablets for Carnitine Deficiencies in Japan

On December 5, Otsuka Pharmaceutical is launching a new form of L-Cartin, L-Cartin Free Form (FF) tablets (generic name levocarnatine) in two doses, 100mg and 250mg.

Mylan Signs Deal With Gilead To Enhance Access To TAF-based HIV Treatments

CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences Inc. (GILD) under which Mylan has licensed the n...

Mylan Signs Deal With Gilead Sciences On Sovaldi And Ledipasvir/Sofosbuvir

CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences Inc. (GILD) under which Mylan has been licensed ...

Mylan And Abbott Labs Amend Agreement On Branded Generics Business

CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) disclosed in a regulatory filing that Mylan Inc., New Moon B.V., a private limited liability company organized under the laws of the Netherlands or 'New Myl...

Mylan, Gilead to Enhance Access to TAF-based HIV Treatments in Developing Countries

Mylan Inc. announced that its subsidiary Mylan Laboratories Limited has entered into an agreement with Gilead Sciences, Inc. under which Mylan has licensed the non-exclusive rights to manufacture and ...

Mylan Unit To Acquire U.S. Commercialization Rights Relating To Arixtra

CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) Wednesday announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, marketing and intellectua...

Mylan to Acquire Arixtra Rights for $225M

Mylan Inc. announced that its subsidiary Mylan Ireland Ltd. has entered into an agreement to acquire the U.S.Read more about Mylan to Acquire Arixtra Rights for $225MComments

Mylan Launches Generic HIV-1 Treatment

Mylan Inc. announced the U.S. launch of its Lamivudine and Zidovudine Tablets USP, 150 mg/300 mg, which is the generic version of Viiv's Combivir. Mylan received final approval from the U.S. Food and ...

Matching PubMed Articles

Epilepsy triggered by mefloquine in an adult traveler to Uganda.

We report a case of a traveler who visited Uganda for 8 d, and took mefloquine one tablet/week for malaria prophylaxis. After the second dose, he suffered from two episodes of loss of consciousness wi...

Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports.

The usefulness of atovaquone-proguanil (AP) as antimalarial treatment is compromised by the emergence of atovaquone resistance during therapy. However, the origin of the parasite mitochondrial DNA (mt...

Notes from the Field: Knowledge, Attitudes, and Practices Regarding Antimalarial Chemoprophylaxis in U.S. Peace Corps Volunteers - Africa, 2013.

Long-term travelers to areas where malaria is endemic are at risk for this potentially fatal disease; however, malaria can be prevented through the use of insecticide-treated bednets, mosquito repelle...

Artenimol + piperaquine. Very slow piperaquine elimination: cardiovascular risks and interactions.

For the treatment of uncomplicated Plasmodium falciparum malaria, drug combinations based on artemisinin derivatives (such as artemether + lumefantrine in France) are an alternative to atovaquone + pr...

Subjective adverse reactions to metronidazole in patients with amebiasis.

Subjective adverse reactions to metronidazole were analyzed in 111 patients with amebiasis. Metronidazole was administered to 36 patients at a daily dose of 2,250mg and 75 patients at daily doses lowe...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement